PHC Stock Overview
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally.
Plant Health Care Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£0.099|
|52 Week High||UK£0.15|
|52 Week Low||UK£0.086|
|1 Month Change||4.63%|
|3 Month Change||-16.99%|
|1 Year Change||-27.45%|
|3 Year Change||80.73%|
|5 Year Change||-63.52%|
|Change since IPO||-82.41%|
Recent News & Updates
|PHC||GB Chemicals||GB Market|
Return vs Industry: PHC matched the UK Chemicals industry which returned -26.7% over the past year.
Return vs Market: PHC underperformed the UK Market which returned -6.8% over the past year.
|PHC Average Weekly Movement||6.6%|
|Chemicals Industry Average Movement||6.9%|
|Market Average Movement||5.4%|
|10% most volatile stocks in GB Market||10.7%|
|10% least volatile stocks in GB Market||2.7%|
Stable Share Price: PHC is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: PHC's weekly volatility (7%) has been stable over the past year.
About the Company
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, citrus, sugar cane, and rice, as well as fruits and vegetables. The company provides Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease.
Plant Health Care Fundamentals Summary
|PHC fundamental statistics|
Is PHC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|PHC income statement (TTM)|
|Cost of Revenue||US$3.43m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.021|
|Net Profit Margin||-74.76%|
How did PHC perform over the long term?See historical performance and comparison
Is PHC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PHC?
Other financial metrics that can be useful for relative valuation.
|What is PHC's n/a Ratio?|
Price to Sales Ratio vs Peers
How does PHC's PS Ratio compare to its peers?
|PHC PS Ratio vs Peers|
|Company||PS||Estimated Growth||Market Cap|
HMI Harvest Minerals
EDEN Eden Research
SYM Symphony Environmental Technologies
HAYD Haydale Graphene Industries
PHC Plant Health Care
Price-To-Sales vs Peers: PHC is good value based on its Price-To-Sales Ratio (4.3x) compared to the peer average (7.7x).
Price to Earnings Ratio vs Industry
How does PHC's PE Ratio compare vs other companies in the GB Chemicals Industry?
Price-To-Sales vs Industry: PHC is expensive based on its Price-To-Sales Ratio (4.3x) compared to the UK Chemicals industry average (3.6x)
Price to Sales Ratio vs Fair Ratio
What is PHC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PS Ratio||4.3x|
|Fair PS Ratio||5.5x|
Price-To-Sales vs Fair Ratio: PHC is good value based on its Price-To-Sales Ratio (4.3x) compared to the estimated Fair Price-To-Sales Ratio (5.5x).
Share Price vs Fair Value
What is the Fair Price of PHC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate PHC's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PHC's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Plant Health Care forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).
Earnings vs Market: PHC is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PHC is expected to become profitable in the next 3 years.
Revenue vs Market: PHC's revenue (34.7% per year) is forecast to grow faster than the UK market (4.1% per year).
High Growth Revenue: PHC's revenue (34.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PHC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has Plant Health Care performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHC is currently unprofitable.
Growing Profit Margin: PHC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PHC is unprofitable, but has reduced losses over the past 5 years at a rate of 20.9% per year.
Accelerating Growth: Unable to compare PHC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PHC is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.8%).
Return on Equity
High ROE: PHC has a negative Return on Equity (-43.91%), as it is currently unprofitable.
Discover strong past performing companies
How is Plant Health Care's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: PHC's short term assets ($14.9M) exceed its short term liabilities ($3.1M).
Long Term Liabilities: PHC's short term assets ($14.9M) exceed its long term liabilities ($704.0K).
Debt to Equity History and Analysis
Debt Level: PHC has more cash than its total debt.
Reducing Debt: PHC's debt to equity ratio has increased from 0% to 1.8% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PHC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PHC has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 22.1% each year.
Discover healthy companies
What is Plant Health Care current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PHC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PHC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PHC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PHC's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PHC has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Jeff Tweedy (54 yo)
Mr. Jeffrey Tweedy also known as Jeff serves as Chief Executive Officer of Plant Health Care plc since June 22, 2022. He has been Chief Operating Officer of Plant Health Care plc since 2018 and also served...
CEO Compensation Analysis
Compensation vs Market: Jeff's total compensation ($USD493.00K) is above average for companies of similar size in the UK market ($USD336.69K).
Compensation vs Earnings: Jeff's compensation has increased whilst the company is unprofitable.
Experienced Board: PHC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: PHC insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Plant Health Care plc's employee growth, exchange listings and data sources
- Name: Plant Health Care plc
- Ticker: PHC
- Exchange: AIM
- Founded: 1995
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Implied Market Cap: UK£30.283m
- Shares outstanding: 304.66m
- Website: https://www.planthealthcare.com
Number of Employees
- Plant Health Care plc
- 242 South Main Street
- Suite 216
- Holly Springs
- North Carolina
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/07 00:00|
|End of Day Share Price||2022/08/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.